Definitive Contract HHSN268201300045C
Award Date 8/30/13
Potential Completion Date 6/5/17
Potential Value $1.7M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- <p>This is a $100,037.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Synzyme Technologies LLC, a for-profit limited liability company. The contract is for the production of stroma-free hemoglobin and hemoglobin-based oxygen carriers (HBOCs). It is a firm-fixed-price definitive contract with a period of performance ending on May 29, 2009.</p>
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Prolong Pharmaceuticals, Inc. for the "Production of Pegylated Hemoglobin". The definitive, firm-fixed price contract has a ceiling value of $101,339.00 and a period of performance ending on January 31, 2009. The contract is focused on biomedical, applied/exploratory research and development.</p>
- <p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Desicorp, Inc. for the development of a thermally stable whole blood product for transfusion. The contract has a firm fixed price of $249,957.36 and a completion date of January 17, 2021. As a Phase I SBIR award, this contract is focused on the initial research and feasibility exploration of the proposed technology. The contract was set aside for small businesses.</p>
- This is a $1,524,172.57 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Cytosorbents Medical Inc. (Cytosorbents) to develop HemoDefend, a hemocompatible, highly porous polymer bead technology designed to broadly remove free hemoglobin, potassium, reactive antibodies, and inflammatory or reactive substances from blood. The contract has a total small business set aside designation, indicating Cytosorbents as the prime contractor. Based on...
- <p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Sigma Genetics Inc., a for-profit organization located in Seattle, WA. The contract, valued at $64,111.00, is for advancing battlefield and global blood supply solutions through novel magnetoporation techniques to create functional lyophilized (freeze-dried) red blood cells with superior trehalose delivery. This research aims to improve the preservation and...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
- This federal contract award, valued at $12,519.50, was issued by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services. The contract was awarded to Government Scientific Source Inc., a for-profit organization based in Reston, Virginia, which specializes in providing laboratory products, scientific equipment, consumables, and diagnostic testing materials to federal agencies. The contract is a Blanket Purchase Agreement (BPA) call, with a...
- This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency under the U.S. Department of Health and Human Services. The prime contractor is Government Scientific Source Inc., a for-profit organization based in Reston, Virginia that specializes in providing laboratory products, scientific equipment, consumables, and diagnostic testing materials to federal agencies. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $86,700.00...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $148,235.00, is for research into using haptoglobin as a treatment to reduce complications of sickle cell disease. The contract has a firm-fixed price and was awarded on August 1, 2012, with a target completion date of March 15, 2013.</p>